Cite
HARVARD Citation
Bartalucci, N. et al. (2013). Co‐targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. Journal of cellular and molecular medicine. 17 (11), pp. 1385-1396. [Online].